SERA PROGNOSTICS INC-A
SERA · NASDAQ
更新於 2026-10-15 10:35:18
- 今日最高
- $2.07
- 今日最低
- $2.03
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $2.03
- 昨天收盤價
- $2.07
- 成交量
- 5.83K
- 市值
- $81.66M
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.66
昨天價格區間
52週價格區間
公司概況
- 板塊
- HEALTHCARE
- 行業
- Biotechnology
- 子行業
- MEDICAL DEVICES
- 總部
- 2749 EAST PARLEYS WAY, SALT LAKE CITY, UT, UNITED STATES, 84109
- 國家
- US
- 上市日期
- 2021-07-15
- 財年截止
- December
- 流通股數
- 39.16M
- CIK
- 0001534969
- 官方網址
- www.sera.com
Sera Prognostics Inc. is a pioneering force in maternal-fetal health, focusing on cutting-edge diagnostic solutions designed to enhance pregnancy outcomes. Its flagship product, the PreTRM test, harnesses a unique biomarker platform to accurately evaluate the risk of preterm birth, enabling healthcare providers to implement timely and impactful interventions. With a steadfast commitment to advancing prenatal diagnostics and addressing pivotal health challenges, Sera is strategically positioned for significant growth within the maternal health sector, offering investors compelling opportunities for long-term value creation.
財務指標
營業收入
2026-06-30
$30K
2026-03-31
$14K
2025-12-31
$10K
2025-09-30
$16K
營業支出
2026-06-30
$9.98M
2026-03-31
$9.33M
2025-12-31
$8.92M
2025-09-30
$8.95M
淨利潤
2026-06-30
-$9.13M
2026-03-31
-$8.39M
2025-12-31
-$7.88M
2025-09-30
-$7.81M
淨利潤率
2026-06-30
-30.46K%
2026-03-31
-59.99K%
2025-12-31
-78.81K%
2025-09-30
-48.83K%
每股收益
2026-06-30
$-0.18
2026-03-31
$-0.17
2025-12-31
$-0.16
2025-09-30
$-0.16
息稅折舊攤銷前利潤
2026-06-30
-$8.94M
2026-03-31
-$8.2M
2025-12-31
-$7.63M
2025-09-30
-$7.56M
有效稅率
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $30K | $14K | $10K | $16K |
| 營業支出 | $9.98M | $9.33M | $8.92M | $8.95M |
| 淨利潤 | -$9.13M | -$8.39M | -$7.88M | -$7.81M |
| 淨利潤率 | -30.46K% | -59.99K% | -78.81K% | -48.83K% |
| 每股收益 | $-0.18 | $-0.17 | $-0.16 | $-0.16 |
| 息稅折舊攤銷前利潤 | -$8.94M | -$8.2M | -$7.63M | -$7.56M |
| 有效稅率 | -- | -- | -- | -- |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。